Funded Tech Companies

TriGemX Bio

TriGemX Bio is a leading biopharmaceutical tech company, based in New York. VC investment was provided by The Column Group, private investors and TCGX.

Company Overview

Company Name
TriGemX Bio
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
430 East 29th St. 8th Floor
New York, NY 10016
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
We are leveraging unique insights into neural signaling pathways and developing innovative medicines for the treatment of migraine. Our late-stage pipeline focuses on delivering an effective, easy to use, first-in-class medication. The company leverages unique scientific insights into neural signaling pathways to target specific peripheral sensory structures.
Profile
TriGemX Bio LinkedIn Company Profile
Social Media
TriGemX Bio Company Twitter Account
Company News
TriGemX Bio News
Facebook
TriGemX Bio on Facebook
YouTube
TriGemX Bio on YouTube
Last Transaction
10/1/2026

Financing History

Date
Type
Amount
Venture Equity
$94,000,000
Venture Equity
$236,000,000
Venture Equity
$112,000,000
Venture Equity
$21,000,000
Venture Equity
$66,000,000
Venture Equity
$44,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeff Goater
  Jeff Goater LinkedIn Profile  Jeff Goater Twitter Account  Jeff Goater News  Jeff Goater on Facebook
Chief Financial Officer
Aninda Katragadda
  Aninda Katragadda LinkedIn Profile  Aninda Katragadda Twitter Account  Aninda Katragadda News  Aninda Katragadda on Facebook
Chief Medical Officer
Brett Lauring
  Brett Lauring LinkedIn Profile  Brett Lauring Twitter Account  Brett Lauring News  Brett Lauring on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Trigemina | Trigence

 

Share this article

 


About Our VC Funding Database

The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary